HepatologyNews.net

Hepatology Xagena

Xagena Mappa
Medical Meeting
Onco News
Mediexplorer.it

A new study has found that patients with severe portal-hypertensive bleeding who are treated with Terlipressin ( Glypressin ) may experience an acute reduction of sodium in their blood.This reduction ...


Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study published in Gastroenterology.This is the first time a study evaluating the combin ...


For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called Telaprevir to the current standard therapy can significantly improve the chances ...


Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer.Hypothyroidism is the most common thyroid disorder among US adults, affecting between 8 and 12 percen ...


Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers.The study found ...


Researchers at The University of Texas MD Anderson Cancer Center have discovered that exposure to the hepatitis B virus ( HBV ) may increase the risk of pancreatic cancer.The study, published in the J ...


Final results from the REPEAT study have demonstrated that treatment with once-weekly Pegasys ( Peginterferon alfa-2a ) and daily Copegus ( Ribavirin ) can achieve viral clearance in a number of patie ...


Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma. The prevalence of ...


For liver transplant recipients without hepatitis C ( HCV ), survival has improved over time. However, for recipients with HCV, survival has not improved. HCV-induced liver disease is the most comm ...


Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis.As liver disease progresses, fibrosis leads to portal hyper ...


A study on risk factors of new-onset diabetes following liver transplant found that a history of obesity, impaired fasting glucose and hepatitis C infection ( HCV ) paired with the use of a particular ...


Individuals with chronic hepatitis C being treated with Interferon ( IFN ) are at risk of developing retinopathy as early as two weeks into treatment according to the results of a study published in t ...


The FDA ( Food and Drug Administration ) has announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is an immune globulin ...


Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis. Researchers showed that activation of hepatic cannabinoid CB2 receptors limits progression ...


Cirrhosis related to non-alcoholic steatohepatitis ( NASH ) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of ...